Breaking: Trump’s FDA, NIH picks win approval from Senate health committee

It's been a tumultuous few weeks for the FDA and NIH as leaders have grappled with mass firings and other efforts to cull the workforce.

Log In    Subscribe BREAKING NEWS   Trump's picks to run FDA and NIH win approval from Senate's health committee By Sarah Owermohle and Lizzy Lawrence Kayla Bartkowski/Getty Images The Senate health committee voted on Thursday to endorse Marty Makary as FDA commissioner and Jay Bhattacharya as director of the NIH. The next step for the nominees is a vote by the full Senate, where a GOP majority all but ensures they will be confirmed. READ MORE Sign up for D.C. Diagnosis Washington never stops. Cut through the noise with our essential updates on health care politics and policy. Learn more. In Case You Missed It White House pulls nomination of Dave Weldon as CDC director hours before hearing By Sarah Owermohle and Lizzy Lawrence On path to likely confirmation as NIH director, Bhattacharya toes the party line By Eric Boodman At hearing, Makary nods to MAHA's goals but says little about basic FDA policies By Lizzy Lawrence Former NIH director Francis Collins, once beloved in Washington, now worries for his safety there By Anil Oza and Katherine MacPhail Get 50% off your first year of STAT+ Have your finger on the pulse of the biotech, pharma, and life science industries with a STAT+ subscription. Subscribe now STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us